Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

High Flow Nasal Cannula Rates in Pediatric Asthma

NCT: NCT06379607 · WITHDRAWN

NCT IDNCT06379607
StatusWITHDRAWN
Start Date2025-01-15
Completion2026-09-30

Brief Summary

This is a randomized, open-label, 3-armed feasibility trial will examine conventional oxygen therapy (COT) vs high flow nasal cannula at 4L/min flow vs HFNC at 2L/kg/min flow (max 60L/min) in moderate to severe pediatric asthma exacerbations.

Frequently Asked Questions

What is High Flow Nasal Cannula Rates in Pediatric Asthma?

High Flow Nasal Cannula Rates in Pediatric Asthma is a clinical trial registered under NCT06379607. Current status: WITHDRAWN.

What is the status of NCT06379607?

The current status of NCT06379607 (High Flow Nasal Cannula Rates in Pediatric Asthma) is: WITHDRAWN.

When did High Flow Nasal Cannula Rates in Pediatric Asthma start?

High Flow Nasal Cannula Rates in Pediatric Asthma started on 2025-01-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.